undamentalytics Newsletter

Jaguar Health, Inc. revenue

Jaguar Health, Inc.'s revenue was $11.5m in fiscal 2025, down 1.5% on the year before. Since fiscal 2015 ($258,381) it has grown at a compound 46.2% a year. Over the last twelve months it was $27.8m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Jaguar Health, Inc.: revenue history, annual
Fiscal year2014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue000446941210121228
Growth on the year before——−45.2%+>999%+1.3%+30.8%+62.5%−53.8%+175.8%−18.4%+19.8%−1.5%—
Gross profit—003226210810823
Gross margin—52.2%63.3%79.8%37.4%33.9%65.1%46.2%83.1%79.1%83.3%67.2%82.3%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Human Health $11.2M 96.9% ▼ 1.9%
Animal Health $353,000 3.1% ▲ 12.1%
Products and services
Line of business Revenue Share YoY
Products $11.3M 99.7% ▼ 1.9%
Mytesi (part of Products) $11M 97.0% ▼ 2.7%
Licenses (part of Products) $172,000 1.5% ▲ 33.3%
Canalevia (part of Products) $148,000 1.3% ▼ 7.5%
Neonorm $35,000 0.3% ▲ 25.0%

From Jaguar Health, Inc.'s 10-K filed April 7, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Jaguar Health, Inc. $27.8m 135.5% 76.5%
Verrica Pharmaceuticals Inc. $30.3m 106.2% 52.2%
Scilex Holding Co $31.6m -28.5% -12.0%
Sunshine Biopharma Inc. $35.3m -2.7% 34.5%
BGM Group Ltd. $37.9m 51.1% —
IM Cannabis Corp. $39.2m -0.7% —

Compare with peers

Head to head: JAGX vs VRCAJAGX vs SCLXJAGX vs SBFM

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Jaguar Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Jaguar Health, Inc.